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Abstract
Induced hypothermia is the only therapy with proven efficacy to reduce brain damage after perinatal
asphyxia. While hypothermia down-regulates global protein synthesis and cell metabolism, low
temperature induces a small subset of proteins that includes the RNA-binding protein RBM3
(RNA-binding motif protein 3), which has recently been implicated in cell survival. Here,
immunohistochemistry of the developing postnatal murine brain revealed a spatio-temporal neuronal
RBM3 expression pattern very similar to that of doublecortin, a marker of neuronal precursor cells. Mild
hypothermia (32°C) profoundly promoted RBM3 expression and rescued neuronal cells from forced
apoptosis as studied in primary neurons, PC12 cells, and cortical organotypic slice cultures. Blocking
RBM3 expression in neuronal cells by specific siRNAs significantly diminished the neuroprotective
effect of hypothermia while vector-driven RBM3 over-expression reduced cleavage of PARP, prevented
internucleosomal DNA fragmentation, and LDH release also in the absence of hypothermia. Together,
neuronal RBM3 up-regulation in response to hypothermia apparently accounts for a substantial
proportion of hypothermia-induced neuroprotection.
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Abstract 
Induced hypothermia is the only therapy with proven efficacy to reduce brain damage after 
perinatal asphyxia. While hypothermia down-regulates global protein synthesis and cell 
metabolism, low temperature induces a small subset of proteins that includes the RNA-
binding protein RBM3 (RNA-binding motif protein 3), which has recently been implicated in 
cell survival. Here, immunohistochemistry of the developing postnatal murine brain revealed 
a spatio-temporal neuronal RBM3 expression pattern very similar to that of doublecortin, a 
marker of neuronal precursor cells. Mild hypothermia (32°C) profoundly promoted RBM3 
expression and rescued neuronal cells from forced apoptosis as studied in primary neurons, 
PC12 cells, and cortical organotypic slice cultures. Blocking RBM3 expression in neuronal 
cells by specific siRNAs significantly diminished the neuroprotective effect of hypothermia 
while vector-driven RBM3 over-expression reduced cleavage of PARP, prevented 
internucleosomal DNA fragmentation, and LDH release also in the absence of hypothermia. 
Together, neuronal RBM3 up-regulation in response to hypothermia apparently accounts for 
a substantial proportion of hypothermia-induced neuroprotection. 
Key words: brain; neuron; apoptosis; infant; asphyxia; hypoxia-ischemia; encephalopathy; 
neuronal stem cell 
Abbreviations: 
RBM3 	 RNA-binding motif protein 3 
CIRP 	 cold inducible protein 
RRM 	 RNA-recognition motif 
COSCs 	 Cortical organotypic slice cultures 
PC12 	 Rat pheochromocytoma cells 
DCX 	 Doublecortin 
NGF 	 Nerve growth factor 
PARP 	 poly ADP-ribose polymerase 
STS 	 Staurosporine 
EGL 	 External granular cell layer 
IGL 	 Internat granular cells layer 
ML 	 Molecular Iayer 
PCL 	 Purkinje cell Iayer 
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Introduction 
The only available therapy for neonatal asphyxia is cooling the infant's body to about 33°C 
(mild hypothermia) for 48-72 h. A series of randomized multicenter trials have established a 
protective effect of therapeutic hypothermia in reducing long-term sequelae (Edwards et al.; 
Jacobs et al., 2007; Schulzke et al., 2007; Shah et al., 2007). 
Hypoxic-ischemic brain damage following asphyxia occurs in a biphasic manner, where the 
early phase (first hours) is classified as necrosis and the later phase (by 48 hours) displays 
characteristics of neuronal apoptosis (Northington et al., 2001a; Northington et al., 2001b). 
Thus, the primary target of hypothermia is the mitigation of early cell death and the 
prevention of delayed neuronal apoptosis (Robertson et al., 2009). 
In neurons, hypoxia-ischemia triggers an intrinsic apoptotic pathway (Ferrand-Drake and 
Wieloch, 1999; Perez-Pinzon et al., 1999; Zhu et al., 2003), characterized by a biochemical 
cascade leading to activation of caspases, cleavage of poly ADP-ribose polymerase (PARP), 
internucleosomal DNA fragmentation, and eventually cell death with release of intracellular 
enzymes, such LDH (Liu et al., 1996; Susin et al., 1999a; Susin et al., 1999b). Hypothermia 
ultimately appears to stop cell death (Edwards et al., 1995; Fukuda et al., 2001; Han et al., 
2002; Zhu et al., 2004) but the precise molecular events of how and where hypothermia 
retards this biochemical cascade are poorly understood. 
The RNA-binding protein RBM3 belongs to a very small group of cold inducible proteins 
being synthesized in response to either hypothermia or other conditions of mild stress 
(Lleonart, 2010). RBM3 is evolutionary highly conserved (Derry et al., 1995) and has been 
suggested to play a role in hibernation (Fedorov et al., 2009; Williams et al., 2005). While a 
temperature drop from 37 to 32-34°C is sufficient to induce the expression of RBM3 (Danno 
et al., 1997), elevated temperature decreases the expression of RBM3 in the setting of 
therapeutic hyperthermia (Zeng et al., 2009) and in cryptorchid testis, a condition in which 
the testes do not descend from the 37°C abdominal compartment to the 33-34°C scrotal 
environment (Danno et al., 2000). 
Recent studies have attributed RBM3 a role in cell survival. Blocking RBM3 signalling by 
siRNAs triggers cells mitotic catastrophe in colon carcinoma cells (Sureban et al., 2008) and 
causes loss of proliferation and ultimately cell death in human embryonic kidney cells (HEK-
293) (Wellmann et al., 2010). In contrast, exogenous over-expression of RBM3 inhibits 
apoptosis in neurons transfected with mutated huntingtin (Kita et al., 2002) and increases 
protein synthesis in mouse neuroblastoma N2a cells (Dresios et al., 2005; Smart et al., 
2007). 
These findings an RBM3 prompted us to hypothesize that the cold-inducible RBM3 might 
serve as a candidate to mediate hypothermia-induced neuroprotection after neonatal 
asphyxia, via its up-regulation in response to hypothermia. Therefore, we first determined 
RBM3 expression in the developing brain of mice. Second, we studied RBM3 induction in 
response to hypothermia in cortical organotypic slice cultures (COSCs), primary neurons and 
rat pheochromocytoma cells (PC12). Third, we investigated whether in PC12 cells 
neuroprotection by hypothermia might involve RBM3, employing siRNA knockdown and 
vector-driven RBM3 over-expression experiments. 
Material and Methods 
Animals, slice preparations, cortical organotypic slice cultures, and primary neurons 
All animal experiments were performed with permission of the local animal care committee 
and in accordance with international guidelines an handling laboratory animals and current 
Swiss law. 
C57BL/6J mice from postnatal day 1, 10, 19, and adult (4 months old) were used. Mice were 
anesthetized with pentobarbital (Vetanarcol®, 0.04 g/kg ip) and perfused with 4% 
paraformaldehyde in 0.1 M phosphate buffer. Brains were dissected and immersed in 4% 
paraformaldehyde overnight. Serial sagittal 40 pm sections were cut with a vibratome and 
collected in cold Tris-phosphate buffer (TBS, 0.05 M). 
COSCs were prepared and cultivated with the classical technique (Stoppini et al., 1991) with 
modifications as published recently by our group (Camenzind et al.). Briefly, brains of 
C57BI/6J postnatal day 4 (P4) or P21 mice were removed and coronal slices of the cortex 
with a thickness of 400 tim were prepared an a tissue chopper. The slices were placed an 
0.4 pm Millicell-CM, 12 mm diameter culture inserts (Millipore, Zug, Switzerland) in six-well 
dishes and cultured in medium containing HEPES-buffered minimal essential medium (50%), 
Hank's buffered salt solution (HBSS, 25%), and heat-inactivated horse serum (25%) 
complemented with glutamax (2 mM; Invitrogen, Basel, Switzerland), glucose (1 g/l) in a 
humidified incubator with 5% CO 2 at either 32°C or 37°C for 72 h. Medium was changed 24 h 
after the COSCs were prepared. 
Primary neuronal cultures were obtained from the cerebral cortex of C57BI/6J mice 
gestational stage E14 as previously described (Ogunshola et al., 2002). Briefly, dissected 
cortices were dissociated in HBSS containing trypsin and DNase I for 5 min at 37°C. 
Neurons were seeded an poly-L-lysine coated petri dishes (1.2 X 10 6 cells per 60 mm dish) 
in Dulbecco's modified Eagle's medium (DMEM)/Glutamax medium containing: B27 
supplement (1X), albumax (0.25g/ml), sodium pyruvate (1%) and 100U/m1 penicillin 
streptomycin, (Invitrogen, Basel, Switzerland). Neurons were maintained in culture for 6 days 
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Immunohistochemistry 
lmmunohistochemistry of free-floating (adult and P19) and mounted sections (younger ages) 
was carried out as described previously (Maetzler et al., 2007). Sections were washed 
thoroughly and solubilized with 0.4% Triton X-100 in 0.1 M phosphate-buffered saline (PBS) 
for 90 min. Non-specific binding was blocked for 2 h in normal goat serum (5 % in PBS 
containing 0.1 M lysine). Then sections were incubated with different preparation of the 
RBM3 antibody (rabbit, 1:500 up to 1:5000, (Wellmann et al., 2010)) overnight at room 
temperature. Biotinylated goat-anti rabbit IgG (1:100; Antibodies, Davis, CA, USA), and the 
avidin-biotin complex (Vector, REACTOLAB, Servion, Switzerland) were applied for 90 min 
each. lmmunoreaction was visualized with 0.05% diaminobenzidine (DAB) and 0.1% H202 
with nickel enhancement (1 % NiSO 4  in the DAB solution). Serial sections were 
immunoreacted for doublecortin (DCX, rabbit polyclonal anti-DCX diluted 1:500 to 1:1000; 
#4604 Cell Signahing) and developed as indicated above. All sections were mounted an 
coated slides, dehydrated in graded ethanol, cleared with xylol and coverslipped in Eukitt 
(Kindler, Freiburg, Germany). 
For co-labeling in COSCs (Camenzind et al., 2010), monoclonal anti-NeuN (diluted 1:250, 
Chemicon, Hofheim, Germany) was incubated together with rabbit polyclonal anti-RBM3 
(diluted 1:100, ProteinTech Group, Chicago, IL, USA) and DAPI (Invitrogen) overnight at 
4°C. Secondary antibodies were anti-rabbit Alexa-488 and anti-mouse Alexa-568 (both 
diluted 1:500, Invitrogen). Slides were incubated for 2 h at room temperature, mounted with 
Vectamount (Vector) and photographed. 
Cell culture 
PC12 were purchased from the German Collection of Microorganisms and Cell cultures 
(DSMZ, Braunschweig, Germany, http://www.dsmz.de/)  and were maintained in DMEM 
supplemented with 5% heat-inactivated fetal calf serum (FCS), 10% heat-inactivated horse 
serum and 100 units penicillin/streptomycin per mL (herein after referred to as complete 
medium, all from Oxoid AG, Pratteln, Switzerland), at 37°C and 5% CO 2 in a fully humidified 
incubator. 
Induction of apoptosis and hypothermia 
PC12 cells, primary neurons and COSCs were treated with various concentrations of 
bacterial alkaloid staurosporine (STS; Sigma-Aldrich Chemie GmbH, Buchs, Switzerland) in 
fresh medium supplemented with 1% horse serum and 0.5% FCS, as indicated. In some 
PC12 experiments, as indicated, apoptosis was induced by serum and glucose deprivation 
(SGD) for 6 h. Forty-eight h after transfection and seeding of PC12 cells in complete media, 
cells were washed twice with PBS, then incubated with PBS for 6 h (SGD), followed by 
rescue with complete medium. For immunoblotting of cleaved PARP, cells were harvested 
4 h after addition of STS 0.8 pM; for assessment of LDH release, cell viability and 
internucleosomal DNA fragmentation cells were harvested 24 to 48 h after addition of 0.2 or 
0.4 pM STS, as indicated. Hypothermia of 32°C was achieved in a Mini Galaxy A incubator 
(Sysmex Digitana, Horgen, Switzerland) and applied for varying times starting either prior (24 
h) or synchronous with induction of apoptosis as indicated. 
RNA-extraction and real-time RT- PCR analyses 
RNA preparation and Reverse Transcription (RT) were performed as described (Weltmann et 
al., 2004). For quantitation, cDNA was amplified by use of SYBR GreenER qPCR SuperMix 
Universal (Invitrogen) and real-time PCR was carried out an a Rotor-Gene 6000 (Corbett Life 
Science, Sydney, Australia) as previously described (Wellmann et al., 2008). Primers for 
detection of the following mouse mRNA molecules have been published previously, RBM3 
and reference gene RPL13A (Wellmann et al., 2004), DCX and p35 (Ge et al., 2006). For 
detection of rat RBM3 mRNA the mouse RBM3 primers could be used due to 100% 
homology and the primers for the rat reference gene RPL13A have been published 
previously (Wellmann et al., 2008). All primers were purchased from Microsynth (Microsynth, 
Balgach, Switzerland). 
Protein extraction and immunoblot analyses 
Total cell protein extraction, quantification and immunoblotting were performed as described 
previously by our group (Shalapour et al., 2006; Wellmann et al., 2004). The following 
antibodies were used: goat polyclonal anti-RBM3 (#EB09201, Everestbiotech, Oxfordshire, 
UK), rabbit polyclonal anti-cleaved PARP (Asp214, Cell Signaling, Danvers, MA, USA), and 
rabbit polyclonal anti-DCX (#4604 Cell Signaling). As an internal control, blots were stripped 
and reprobed with rabbit polyclonal anti-ß-actin (#4967, Cell Signaling). Bound antibodies 
were detected using secondary antibodies conjugated with horseradish peroxidase rabbit 
anti-goat (Invitrogen) and goat anti-rabbit (Cayman, Ann Arbor, MI, USA). Finally the 
enhanced chemiluminescence system (ECL, Amersham, GE Healthcare, Glattbrugg, 
Switzerland) was applied 
RBM3 over-expression and short interfering RNA 
The sequence of the rat RBM3 gene GenBank NM_053696 was optimized for increased 
mammalian expression, re-synthesized chemically by GENEART (GENEART company, 
Regensburg, Germany) and cloned into the expression vector pCEP4 (Invitrogen). 2x10 6 
 PC12 cells were transfected either with the RBM3 containing vector or the empty vector, 
serving as control. For transient down-regulation of rat RBM3 mRNA 2x10 6 PC12 cells were 
transfected either with RBM3 specific siRNA sequences (Rn_Rbm3_1 and Rn_Rbm3_4; 
Qiagen, Hombrechtikon, Switzerland) or control siRNA molecules (AllStars Negative 
Control siRNA; Qiagen). All transfections were performed by use of Nucleofector 
technology according to the manufacturer's instructions for PC12 cells (Cell Line Kit V; 
Lonza, Basel, Switzerland). After transfection PC12 cells were plated in four to six collagen-
coated 20 mm dishes (BD-Biosciences) with complete medium. Then, 24 h after 
transfection, plates were subjected to the various experiments as indicated. Previously, two 
RBM3 isoforms have been described differing in one arginine at position 137, encoded by 
the first three bases of exon 6, isoform Arg+ and Arg- (Smart et al., 2007). Our RBM3- 
overexpression vector codes for the complete RBM3 protein, including arginine at position 
137. The here used siRNA-sequences target specific sequences downstream of exon 6, 
within the untranslated region of exon 7 and therefore silence RBM3 signalling of both 
isoforms, Arg+ and Arg-. 
Cell viability, LDH release, and internucleosomal DNA fragmentation 
Viability of cells was examined by use of the MTS [3-(4,5-dimethylthiazol-2-y1)-5-(3- 
carboxymethoxypheny1)-2-(4-sulfopheny1)-2H-tetrazolium] tetrazolium assay according to the 
manufacturers recommendations (Cell Titer96 Aqueous, Promega, Dubendorf, Switzerland). 
LDH release was examined by Cytotoxicity Detection Kit PLus LDH and internucleosomal DNA 
fragmentation by Cell Death Detection ELISAPLus (Roche, Rotkreuz, Switzerland). In 
experiments with primary neurons, LDH release is given as absorbance (490-620), in some 
experiments with PC12 cells LDH release is given as fold change relative to control and in 
some as percentage of total cell lysis, as indicated. Total cell lysis was achieved by adding 
supplied lysis reagent to control cells cultivated in parallel according to the manufacturers 
recommendations. 
Statistical analysis: 
Statistical significance was determined using the matched pairs test. Student's t test was 
performed for each pair of data separately. Significance with a p<0.05 is reported. 
Results 
RBM3 is expressed in the developing mouse brain in a temporally and spatially 
restricted pattern 
During postnatal murine brain development, RBM3 levels were found to be high immediately 
after birth (P1) and low in adult brain, paralleled by a very similar DCX and p35 mRNA and 
protein expression dynamic (Fig. 1A and 1B). DCX is a microtubule associated protein and is 
expressed in newborn and migrating neurons as well as in neuronal stein cells of the adult 
brain (for review of DCX and p35 see Feng and Walsh, 2001). The decrease in mRNA 
expression alongside maturation was stronger for DCX than for RBM3, while p35 exhibited 
only a moderate decrease (Fig. 1A). 
At the immunohistochemical level, RBM3 was expressed in most neurons of the brain during 
the first postnatal days (not shown). In the course of development, RBM3 expression 
decreased in parallel with the maturity of the neurons. Thus, in the somatosensory cortex of 
P10 mice early generated neurons of the deep layers expressed RBM3 at a low level, while 
later generated neurons in the upper layers exhibited stronger RBM3 immunoreactivity (Fig. 
2A). In the early developing cerebellar cortex, RBM3 was present in the external granule 
layer (EGL) where the granule cells are generated. The centripetal migrating neurons (Fig. 
2B and 2D) which cross through the molecular layer (ML) and the Purkinje cell layer (PCL) 
were RBM3 positive. At the place where they reach their final destination, the internal 
granule cell layer (IGL), RBM3 expression was absent (Fig. 2B and 2D). DCX was found to 
stain the same type of cells in the same time pattern as RBM3 (Fig. 2C and 2E). 
In contrast, in adult brain, RBM3 expression was restricted to very few neurons in the 
hippocampus and the forebrain. The localisation of these cells in the subgranular layer of the 
adult hippocampus together with a very similar staining pattern found for DCX in parallel 
sections, suggests that neuronal stein cells of the dentate gyrus express RBM3 (Fig. 3A and 
3B). The same is true for the rostral stream, where the neuronal progenitor cells for the 
olfactory bulb are residing (Fig. 3C and 3D). Cells of the subventricular zone were also found 
to express RBM3 (see Fig. 2). 
Mild hypothermia (32°C) induces RBM3 expression in cortical organotypic slice 
cultures and primary neurons. 
Next, we investigated RBM3 in murine COSCs drawn from temporal cortex of newborn (P4) 
and adult littermates (P21). Basal RBM3 mRNA expression (at 37°C) was found to be about 
3-fold higher in newborn, as compared to young adult mice (Fig. 4A). In response to 72 h of 
mild hypothermia (32°C), RBM3 mRNA was up-regulated in the P21 mice (2.8-fold) and in 
the P4 mice (5-fold, Fig. 4A). Analyses of RBM3 protein expression confirmed this finding 
(Fig. 4B). Primary murine neurons exhibited a robust increase in RBM3 mRNA expression 
even after 24 h of mild hypothermia (Fig. 4C). 
Immunohistochemistry of COSCs showed upregulation of RBM3 in response to hypothermia 
for 72 h as compared to normothermia (Fig. 5). RBM3 was particularly expressed in neurons 
as shown by double-labeling with NeuN. In addition, RBM3 upregulation was present in 
immature neurons as exemplified by the staining of the subventricular zone (SVZ), which is 
not Iabelled by the marker for mature neurons NeuN (Fig. 5). A few unidentified cells were 
also positive for RBM3 which may represent immature neurons or glial cells. 
lnduced apoptosis in primary neurons and PC12 cells is diminished by mild 
hypothermia (32°C) 
STS is an established agent for inducing classical (caspase-dependent) apoptosis in 
neurons. Primary neurons as well as PC12 cells when cultured under mild hypothermic 
(32°C) conditions were significantly less vulnerable to STS as shown by determination of 
LDH release (Fig. 4D and Fig. 4E, respectively). 
The effect of hypothermia an alleviating STS induced apoptosis was most intense when 
hypothermia commenced 24 h prior to induction of apoptosis and continued throughout the 
experiment, irrespective of the STS concentrations employed (Fig. 4E, temperature profile 
32/32). When comparing either exclusive pre- (32/37) or post-cooling (37/32), the anti-
apoptotic effect of hypothermia was more effective in the experiments with post-cooling, 
irrespective of the used STS concentration (Fig. 4E). 
siRNA-mediated RBM3 down-regulation impedes the protective effect of mild 
hypothermia (32°C) 
Down-regulation of RBM3 mRNA expression to less than 90% of control levels was achieved 
in PC12 cells by combining two siRNA sequences directed against rat RBM3. After 
transfection (up to 72 h) of PC12 cells with either siRNA directed against RBM3 or nonsense 
mRNA, there was no significant difference with respect to cell viability (MTS assay) and 
apoptosis (DNA fragmentation and LDH release, Fig. 6A). However, when PC12 cells were 
cultured after siRNA transfection in mild hypothermic conditions (32°C) and were exposed to 
STS, the protective effect of hypothermia was almost completely abolished in the RBM3- 
silenced PC12 cells. This was shown by cleavage of PARP, internucleosomal DNA 
fragmentation, and determination of LDH release (Figure 5B, C, and D, respectively). 
Vector-based RBM3 over-expression mimics the protective effect of mild hypothermia 
(32°C) 
Two days after transfection of PC12 cells with either the RBM3-pCEP4 expression-vector or 
the empty control vector, cells were treated either with STS (Fig. 7A-7B) or with SGD for 6 h 
following complete medium for 42 h (Fig. 7C). RBM3 over-expressing cells had less cleavage 
of PARP, internucleosomal DNA fragmentation, and LDH release, as compared to controls. 
Discussion 
Here, we present several lines of evidence for an involvement of the cold-inducible 
RNA binding protein RBM3 in mediating hypothermia-induced neuroprotection. First, RBM3 
is widely expressed in juvenile neurons of murine brain. Second, mild hypothermia of 32°C 
causes significant RBM3 mRNA and protein up-regulation in juvenile as well as in adult 
neurons. Third, the degree of neuronal apoptosis is inversely related to the level of RBM3 
expression. Fourth, blocking RBM3 over-expression that normally follows mild hypothermia 
(32°C) in cultured neuronal cells diminishes the protective effect of hypothermia. Fifth, 
inducing RBM3 expression even under euthermic conditions (37°C) endows neuronal cells 
with more resistance against induction of apoptosis. 
Our observations an the spatiotemporal RBM3 protein expression during murine postnatal 
brain development are in line with the recent findings in rats (Pilotte et al., 2009). An overall 
high neuronal RBM3 expression in the first postnatal week of mice (Fig. 1 and 2) 
corresponds to a climax in RBM3 protein expression in the second postnatal week of rats 
(Pilotte et al., 2009). In both species, RBM3 expression becomes restricted to the remaining 
neuronal proliferative zones of the olfactory bulb and the hippocampus when animals grow 
up (Fig. 3). Thus, RBM3 appears to be among several other RNA-binding proteins exhibiting 
a common dynamic expression pattern, peaking early after birth and then declining 
(Hambardzumyan et al., 2009; McKee et al., 2005). This coordinated temporal expression 
wave parallels neuronal requirements of translational rate (Pilotte et al., 2009). Within the 
group of RNA-binding proteins, RBM3 and the highly related cold inducible RNA-binding 
protein (CIRP) stand out due to their cold-inducibility (Lleonart, 2010). 
On the one hand we performed a developmental study in mice from P1 up to adulthood. P10 
and 19 are just representative examples (Fig. 2). On the other hand, to demonstrate RBM3 
expression in response to hypothermia, we used COSCs from early postnatal animals (P4) to 
mimic the situation in the newborn infant (Fig. 4A, 4B, and 5). P21 animals are the oldest 
animals from which COSCs can be generated. Therefore, we selected this age to show the 
reaction in a brain as mature as possible (Fig. 4A). 
STS, a broad spectrum protein kinase inhibitor, induces cell death by triggering the intrinsic 
apoptotic pathway involving cytochrome c release from mitochondria (Johansson et al., 
2003). Exposure of PC12 cells to STS has been studied extensively to investigate either 
neuronal differentiation by application of low concentrations (range of 10 nM) (Demeneix et 
al., 1990; Rasouly et al., 1996) or induced apoptosis when applied at high concentrations (up 
to 1 pM) (Xia et al., 1995). In response to nerve growth factor (NGF), PC12 cells differentiate 
into neuronal cells with neurite extensions (Greene, 1978). In our experiments presented 
here, naive PC12 cells were used due to the following considerations: First, for transfection, 
cells had to be collected according to the nucleofector protocol and then replated in new 
dishes, thus in case of prior differentiation cells may lose their differentiated phenotype 
including neurites. Second, the effect of transient siRNA transfection is too short to render 
the possibility of a subsequent differentiation by NGF over a couple of days. Third, it is 
unknown how treatment of NGF affects RBM3 expression. However, to fully understand the 
rote of RBM3 in cold-induced neuroprotection appropriate in vivo experiments with transgene 
animals are required. 
The use of LDH release assay to monitor apoptosis in neurons is still an debate. However, 
while LDH release was originally used to measure neuronal cell death occurring from 
necrosis (Koh and Choi, 1987), in more recent publications it was shown, that by means of 
LDH release neuronal apoptosis in cortical cultures is accurately detected (Gwag et al., 
1995; Koh and Cotman, 1992). In a comparative study of LDH and MTT assays in cortical 
cell cultures with induced neuronal apoptosis by exposure to various pro-apoptotic stimuli 
some benefits were noted when using LDH release assays (Lobner, 2000). We decided not 
to use MTT assay as this assays quantifies mitochondrial activity which might be reduced by 
hypothermia, thus negatively affecting comparability of cooled and uncooled samples. The 
boundaries between apoptosis, necrosis and other forms of cell death are less distinct than 
previously thought (Vandenabeele et al.), particularly so in neurons (Yuan et al., 2003). 
Further investigations will have to elucidate the mechanisms of RBM3 action, including the 
physical RBM3 interaction partners and the target molecules of RBM3 signalling in 
neuroprotection. RBM3 belongs to a small group of RNA-binding proteins that contains only 
one single RNA-recognition motif (RRM) (Lleonart, 2010). RRMs are extremely diverse in 
terms of both structure and function and bind RNA species as well as proteins (Maris et al., 
2005). Evidence suggests that two or more RRMs located within the same protein are 
required for full action (Clery et al., 2008). Moreover, it is now known that regulated gene 
expression at the post-transcriptional level is based on a network of interactions among 
RNA-binding proteins operating within multifactorial ribonucleoprotein complexes (Glisovic et 
al., 2008). Therefore, it is not surprising that several RNA-binding proteins exhibit a common 
dynamic expression pattern during postnatal brain development (Hambardzumyan et al., 
2009; McKee et al., 2005). Previous reports found RBM3 to be associated with ribosomal 
subunits (Dresios et al., 2005; Smart et al., 2007) and at least one heterogenous 
ribonucleoprotein (Sureban et al., 2008). 
Exposure of mammalian cells to mild hypothermia causes a general inhibition of protein 
synthesis (Burdon, 1987). The observation that RBM3 has a positive effect on protein 
synthesis suggests that RBM3 may prevent a more dramatic reduction of protein synthesis 
under conditions of hypothermia (Dresios et al., 2005; Smart et al., 2007). However, it is 
unlikely that RBM3 rescues neuronal cells from apoptosis by merely stabilizing the 
translational machinery. Thus, we propose that in a fashion similar to the specific stabilization 
of cyclooxygenase-2 (COX-2) mRNA in colon carcinoma cells (Cok et al., 2004; Sureban et 
al., 2008), a number of specific target mRNAs are stabilized by RBM3 in neuronal cells. The 
cold inducible protein CIRP, also known as heterogenous ribonucleoprotein A18, shares high 
homology with RBM3, especially in the RRM (Lleonart, 2010). lt has recently been found to 
induce the expression of thioredoxin and thereby protecting cells from oxidative stress and 
apoptosis through quenching reactive oxygen species (Yang et al., 2006). Furthermore, a 
role for CIRP has recently been established in preserving the stemness of neural stem cells 
and suppressing apoptosis of the cells in conditions of moderate low temperature (32°C) 
(Saito K. et al., 2010). 
Our experiments performed an the COSCs are the first to show the effect of hypothermia an 
RBM3 expression in intact brain tissue. Ultimate proof of the neuroprotective action of RBM3 
will require in vivo experiments employing RBM3 transgenic animals which are not available 
at present. The signalling cascades upstream and downstream of RBM3 also remain to be 
elucidated. 
While RBM3 which is expressed in brain neurons in a spatiotemporally restricted fashion, its 
hypothermia-mediated upregulation may rescue neuronal cells from apoptosis and thus 
contribute to the clinical efficacy of cooling asphyxiated newborn infants. 
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Figure legends 
Fig. 1. RBM3 mRNA and protein expression during postnatal brain development. Panel A: 
mRNA expression of DCX (grey columns), RBM3 (black), and p35 (white) is given relative to 
P1 and was determined in three brain regions as indicated. In each postnatal day of 
assessment (developmental age), indicated with P1, P10, P18, and Ad for adult, 3-5 animals 
were investigated. Columns, mean mRNA expression in samples of 3-5 animals performed in 
triplicates, bars, ± s.d. * p<0.05 relative to P1. Panel B: Representative immunoblot for the 
indicated antigens of the various brain regions and postnatal days of assessment (Dev. age, 
developmental age) as given. 
Fig. 2. Presence of RBM3 in the postnatal mouse brain. A: In the developing (P10) 
somatosensory cortex overlying the hippocampus (CA1), increased expression is found in 
cells of the subventricular zone (SVZ), in recently migrated neurons (arrows) and in 
numerous cells of the second cortical layer (L II). B and C: In the early developing cerebellar 
cortex (P10), RBM3 and DCX are expressed in the external granular cell layer (EGL) as 
shown in neighbouring sections. Similar to DCX, RBM3 is present in single cells (arrows in 
the high magnification insets) crossing the molecular layer (ML) and the Purkinje cell layer 
(PCL) an the way to the internal granular cell layer (IGL). D and E: At P19, few neurons 
(arrows) still migrate to their final destination in the IGL. These migrating neurons express 
RBM3 and DCX (arrows). In contrast to DCX, RBM3 is present in Purkinje cells in early 
development (see B) but not at later stages (see D). 
Fig. 3. Presence of RBM3 in the adult mouse brain. A and B: In adult hippocampus, neuronal 
stem cells, within the subgranular layer (SGL), express RBM3 and DCX. C and D: Progenitor 
cells for the olfactory bulb are present in the rostral migratory stream (RS), which separates 
the prefrontal cortex (Cx) from the underlying basal forebrain, express RBM3 and DCX. 
Fig. 4. Effect of hypothermia an RBM3 expression and apoptosis in murine COSCs, primary 
neurons, and PC12 cells. Panel A: RBM3 mRNA expression normalized to RPL13 mRNA in 
cortical slices when cultured 72 h at 37 or 32°C, postnatal day P4 and P21, as indicated. 
Columns, mean mRNA expression in samples of 6 animals performed in triplicates, bars, ± 
s.d. * p<0.05 relative to COSCs maintained at 37°C of each group. Panel B: Representative 
immunoblot for RBM3 and ß-actin of COSCs derived from postnatal day P4 and cultured as 
indicated. Panel C: RBM3 mRNA expression normalized to RPL13 mRNA in primary 
neurons, exposed to 37°C or 32°C for 24 h. Columns, mean of 3 experiments performed in 
triplicates, bars, ± s.d. * p<0.05 relative to neurons maintained at 37°C. Panel D: LDH 
release of primary neurons treated with various concentrations of STS either at 37°C or 32°C 
for 48 h. Columns, mean of 3 experiments performed in triplicates, bars, ± s.d. * p<0.05 
relative to neurons maintained at 37°C of each group. Panel E: PC12 cells were exposed to 
four different temperature (°C) profiles prior (24 h) and subsequent (48 h) STS treatment as 
indicated. LDH release is given as fold change relative to STS-untreated PC12 cells. Data 
are representative of three independent experiments; columns, mean of quintuplicates, bars, 
± s.d. Significance was calculated between corresponding STS-treated PC12 cells of the 
37/37 group and the three other groups, * p<0.05. 
Fig. 5. In COSC obtained from postnatal day 4 mice, RBM3 is present after 3 days in culture. 
In slices exposed to hypothermia (32°C) RBM3 is highly concentrated in nuclei (A), as 
compared to slices cultured at normothermia (37°C; F). NeuN, a marker of differentiated 
neurons, exhibits a similar expression at 32°C (B) and 37°C (G) and is strongly colocalized 
with RBM3 (C and H). The nuclear stain DAPI allows to identify the cortical layers (D and I) 
and shows that under hypothermia, RBM3 is not only present in differentiated neurons but 
also in the subventricular zone (SVZ) and in unidentified cells of the developing cortex (E and 
J). 
Fig. 6. Influence of RBM3 silencing on apoptosis and neuroprotection by hypothermia in 
PC12 cells. PC12 cells were transfected either with siRNA targeting RBM3 mRNA (R) or 
control mRNA (c) as indicated. Panel A shows the effect of RBM3 down-regulation without 
further treatment. Exposure of PC12 cells to either hypothermia (32°C) or normal 
temperature (37°C) started 24 h prior to STS treatment as indicated (panel B, C, and D). For 
immunoblotting of the indicated antigens (RBM3, cleaved PARP (cl. PARP), and ß-actin) 
cells were harvested already 4 h after STS treatment, panel B. For assessment of viability 
(MTS assay, panel A), DNA fragmentation (panel A and C) and LDH release (panel A and D) 
cells were harvested 48 h after STS treatment. All data shown are representative of at least 
three independent experiments and columns, average of quintuplicates, bars, ± s.d. 
Student's t-tests were conducted in A, C and D using a criteria of p<0.05 for significance, 
marked by asterisks. 
Fig. 7. Influence of RBM3 over-expression on apoptosis and neuroprotection in PC12 cells. 
PC12 cells were transfected with empty (con) or RBM3 pCEP4 expression vector. For 
immunoblotting of the indicated antigens (RBM3, cleaved PARP (cl. PARP), and ß-actin) 
cells were harvested already 4 h after STS treatment, panel A. For assessment of DNA 
fragmentation or LDH release cells were harvested 48 h after STS treatment (panel B) or 
after 6 h serum-glucose deprivation (SGD) following 42 h complete medium (panel D). All 
data shown are representative of at least three independent experiments and columns, 
average of quintuplicates, bars, ± s.d.; Student's t-tests were conducted in B, C and D using 
a criteria of p<0.05 for significance, marked by asterisks. 
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